chr16-2091460-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM1BS2
The NM_001009944.3(PKD1):c.11675G>A(p.Arg3892His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000664 in 1,260,028 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00036 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00070 ( 3 hom. )
Consequence
PKD1
NM_001009944.3 missense
NM_001009944.3 missense
Scores
3
8
8
Clinical Significance
Conservation
PhyloP100: 2.33
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM1
In a topological_domain Extracellular (size 214) in uniprot entity PKD1_HUMAN there are 39 pathogenic changes around while only 11 benign (78%) in NM_001009944.3
BS2
High AC in GnomAd4 at 54 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.11675G>A | p.Arg3892His | missense_variant | 42/46 | ENST00000262304.9 | NP_001009944.3 | |
PKD1-AS1 | NR_135175.1 | n.25C>T | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.11675G>A | p.Arg3892His | missense_variant | 42/46 | 1 | NM_001009944.3 | ENSP00000262304 | P5 |
Frequencies
GnomAD3 genomes AF: 0.000364 AC: 54AN: 148448Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
54
AN:
148448
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000768 AC: 8AN: 10416Hom.: 0 AF XY: 0.000866 AC XY: 6AN XY: 6928
GnomAD3 exomes
AF:
AC:
8
AN:
10416
Hom.:
AF XY:
AC XY:
6
AN XY:
6928
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000704 AC: 783AN: 1111580Hom.: 3 Cov.: 32 AF XY: 0.000712 AC XY: 383AN XY: 538142
GnomAD4 exome
AF:
AC:
783
AN:
1111580
Hom.:
Cov.:
32
AF XY:
AC XY:
383
AN XY:
538142
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000364 AC: 54AN: 148448Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 32AN XY: 72264
GnomAD4 genome
AF:
AC:
54
AN:
148448
Hom.:
Cov.:
33
AF XY:
AC XY:
32
AN XY:
72264
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 14, 2022 | Variant summary: PKD1 c.11675G>A (p.Arg3892His) results in a non-conservative amino acid change located in the Polycystin cation channel (PKD1/PKD2) domain (IPR013122) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00037 (54 heterozygotes) in 147232 control chromosomes (gnomAD v3.1, genomes dataset). The high number of heterozygous carriers argues against a fully penetrant autosomal dominant disease association for the variant. The variant, c.11675G>A, has been reported in the literature in at least two adult individuals affected with polycystic kidney disease, however without supportive evidence for causality (Neumann_2013, Audrezet_2016). In addition, the variant was also reported in early onset polycystic kidney disease, together with other variants, therefore the authors of this study proposed hypomorphic role for this variant, with a potential biallelic or digenic inheritance (Durkie_2020). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Polycystic kidney disease, adult type Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 27, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 09, 2021 | - - |
PKD1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 29, 2024 | The PKD1 c.11675G>A variant is predicted to result in the amino acid substitution p.Arg3892His. This variant was previously reported in one patient with polycystic kidney disease (PKD), but no functional or genetic studies were performed to help assess the pathogenicity of this variant (Neumann et al. 2013. PubMed ID: 23300259). This variant along with a truncating variant in the PKD2 gene was reported in one case with very early onset PKD; and in the second case with very early onset PKD, this variant was reported in the compound heterozygous state with another PKD1 variant, suggesting this variant could be a hypomorphic allele. By itself, this type of variant may cause no disease or only relatively mild disease. However, in combination with other pathogenic variants, it may contribute to disease severity (Durkie et al. 2021. PubMed ID: 33168999). This variant is reported in 0.096% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Pathogenic
Sift
Benign
T;T
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Loss of sheet (P = 0.0457);.;
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at